0.68 - 0.75
0.33 - 0.86
18.34M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-19.48%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-23.42%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-78.76%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-78.76%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-98.53%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-98.40%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-98.40%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.03%
Slight or no buybacks while 0259.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.00%
Slight or no buyback while 0259.HK is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
457531.89%
Maintaining or increasing dividends while 0259.HK cut them. John Neff might see a strong edge in shareholder returns.
40.99%
Positive OCF growth while 0259.HK is negative. John Neff would see this as a clear operational advantage vs. the competitor.
40.27%
Positive FCF growth while 0259.HK is negative. John Neff would see a strong competitive edge in net cash generation.
-67.49%
Negative 10Y revenue/share CAGR while 0259.HK stands at 21.88%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-15.33%
Negative 5Y CAGR while 0259.HK stands at 5.94%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-28.41%
Negative 3Y CAGR while 0259.HK stands at 22.30%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-1697.85%
Negative 10Y OCF/share CAGR while 0259.HK stands at 463.23%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-72.92%
Negative 5Y OCF/share CAGR while 0259.HK is at 171.89%. Joel Greenblatt would question the firm’s operational model or cost structure.
34.00%
3Y OCF/share CAGR at 50-75% of 0259.HK's 65.23%. Martin Whitman would suspect weaker recent execution or product competitiveness.
-98.53%
Negative 10Y net income/share CAGR while 0259.HK is at 111.68%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-96.55%
Negative 5Y net income/share CAGR while 0259.HK is 37.10%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
100.61%
3Y net income/share CAGR above 1.5x 0259.HK's 44.34%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
38.18%
Below 50% of 0259.HK's 153.27%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
39.20%
5Y equity/share CAGR at 75-90% of 0259.HK's 45.88%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
20.11%
3Y equity/share CAGR at 50-75% of 0259.HK's 27.41%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
-19.39%
Cut dividends over 10 years while 0259.HK stands at 700.01%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-55.55%
Negative 5Y dividend/share CAGR while 0259.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
-0.54%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-10.88%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.46%
Positive asset growth while 0259.HK is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
0.69%
Positive BV/share change while 0259.HK is negative. John Neff sees a clear edge over a competitor losing equity.
-2.75%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-3.46%
Our R&D shrinks while 0259.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-13.08%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.